Sign up | Login with →

Why drug price regulation should not be ruled out

October 1, 2015 by David E Williams

I’m a proponent of free markets and in general defend drug companies in their price setting, especially when they’re introducing new, innovative products with real clinical and financial benefits. See, for example, Hooray for high-...[read more]


Bacteriophages: A Ray of Hope in the Fight against Antibacterial Resistance?

September 29, 2015 by Varsha Jain

Resistance to antibiotics is currently one of the world’s most pressing issues related to public health. Almost all classes of common and potentially deadly bacteria have become strong and less responsive to antibiotic treatments over the years. In...[read more]

Top at Risk DRG’s in the Post ICD-10 Era & How to Proactively Address Coding Challenges

September 28, 2015 by Phil C. Solomon

 ICD-10 is expected to be fraught with significant challenges to coding quality because:Dealing with a very new coding and documentation paradigmThe predictability in coding due to an unpredictable financial environmentLimited experience in DRG...[read more]

Facebook Fundamentals: Being “Social” Where It Counts

September 28, 2015 by Stewart Gandolf, MBA

Far and away, Facebook is the most popular social media site on the planet. For healthcare marketing, that makes it a first class opportunity to communicate with patients and prospective patients.

[Article Series: An excerpt from a forthcoming book by Mark Tager, MD, and Stewart Gandolf, MBA, for private practice physicians and healthcare administrators about reaching, recruiting and retaining private pay and elective care patients.] Far...[read more]

12 Common IRO Questions Answered

September 28, 2015 by Moira O'Connell

Independent Review Organizations (IROs) exist to “ensure thatevidence-based and objective physician review services are provided along the continuum of care. IROs act as a third part and help alleviate the pressure of reviewing claims and make decisions without influence from either end of the situation.” We’ve been talking a lot about the major benefits that external IROs can provide, from helping support effective decision making to giving objective, unbiased reviews. We thought we would take this week to give some IRO basics, for those who want help understanding exactly what IROs are and what they does.[read more]

Heroes Behind the Counter & In Other Places

September 28, 2015 by Michael Kirsch

  The Marvelettes in 1963Patients are cool.   I did a colonoscopy on a hospitalized man who was saddled with the ravages of obesity, diabetes, sleep apnea and respiratory disease.  My partner had performed the initial...[read more]

Poll Finds Overwhelming Support For Medicare Paying For End-Of-Life Talks

October 2, 2015 by Liz Seegert

via Kaiser Health News The public overwhelmingly supports Medicare’s plan to pay for end-of-life discussions between doctors and patients, despite GOP objections that such chats would lead to rationed care for the elderly and ill, a poll released Wednesday finds. Eight of 10 people surveyed by the Kaiser Family Foundation supported the...[read more]

Blogging and Teaching

October 1, 2015 by Christina Thielst

Tomorrow is the first day of my 2015 Annual Online Seminar for ACHE and the topic we will explore is a Digital Revolution: How Health IT can Improve Access, Quality, Safety and Efficiency. I've enjoyed guiding the participants through the topics , for several years now, as we explore the tools that are disrupting healthcare and helping...[read more]


How Much Liposuction is Safe? The Answer Differs for Everyone

September 29, 2015 by Jenna Cyprus

Liposuction is always a hot topic, particularly when it comes to ethics. Another hot topic revolves around how much is acceptable for each patient. Many patients who see a professional about liposuction want more out of the surgery than the doctor agrees to give. In fact, it’s dangerous to give a patient more liposuction than the amount that’s been designated by the American Society of Plastic Surgeons (ASPS).[read more]


Implantable Drug Delivery Systems: Delivering Medication One Dose at a Time

September 28, 2015 by Nishita Pereira-Gracias

Controlled, site-specific release of drugs and other therapeutic agents has emerged as a rather attractive alternative for companies that are looking to boost the efficacy of an existing product.Thebigger winner, however, is the patient.A significant advantage that implantable drug delivery systems render via targeted therapies is fewer...[read more]